Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 3 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar beadnell (26.17) Submitted: 8/23/2011 4:32:17 AM : Outperform Start Price: $4.38 PTIE Score: -30.67

I'm dabbling in microcaps on CAPS

Report this Post Reply

Featured Broker Partners


Advertisement